Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery-The RECOVER Study

Next Previous
Trial Profile

Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery-The RECOVER Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 06 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Opioid-related disorders
  • Focus Therapeutic Use
  • Acronyms RECOVER
  • Sponsors Indivior

Most Recent Events

  • 01 May 2022 Results investigating diverse array of outcomes for individuals with OUD at an average of 4.2 years post clinical trial participation from NCT023579011; NCT025100142; NCT02896296 & NCT03604861 were published in the Drug and Alcohol Dependence.
  • 24 Jun 2020 According to an Indivior media release, Warren K. Bickel, a professor at Fralin Biomedical Research Institute at Virginia Tech Carilion, is leading the next phase of this RECOVER study, which researchers hope will provide further information to health care systems and policymakers on how continuity of care can help address the nations opioid crisis.
  • 24 Jun 2020 According to an Indivior media release, Walter Ling, MD, (Research Professor, Department of Family Medicine, David Geffen School of Medicine, UCLA) is the lead author of this study.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top